¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Nuclear Respiratory Factors"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nuclear sex
    ÇÙ¼ºº°
  • nuclear shift
    ÇÙÀ̵¿
  • nuclear spindle
    ÇÙ¹æÃß
  • nuclear stain
    ÇÙ¿°»ö
  • nuclear-cytoplasmic ratio
    ÇÙ¼¼Æ÷Áúºñ
  • progressive nuclear ophthalmoplegia
    ÁøÇà½Å°æÇÙ´«±ÙÀ°¸¶ºñ
  • acute respiratory distress syndrome
    ±Þ¼ºÈ£Èí°ï¶õÁõÈıº
  • adult respiratory distress syndrome
    ¼ºÀÎÈ£Èí°ï¶õÁõÈıº
  • hypoxemic respiratory failure
    Àú»ê¼ÒÇ÷ÁõÈ£Èí±â´É»ó½Ç, Àú»ê¼ÒÇ÷ÁõÈ£ÈíºÎÀü
  • idiopathic respiratory distress
    Ư¹ßÈ£Èí°ï¶õ
  • idiopathic respiratory distress syndrome
    Ư¹ßÈ£Èí°ï¶õÁõÈıº
  • medullary respiratory center
    ¼û³úÈ£ÈíÁßÃß, ¿¬¼öÈ£ÈíÁßÃß
  • medullary respiratory chemoreceptor
    ¼û³úÈ£ÈíÈ­Çмö¿ëü
  • nonprotein respiratory quotient
    ºñ´Ü¹éÁúÈ£ÈíÁö¼ö
  • respiratory
    1. È£Èí- 2. È£Èí¼º-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nuclear stain
    ÇÙ¿°»ö
  • nuclear fast red
    ÇÙ³»Àû»ö¼Ò
  • nuclear magnetic resonance
    ÇÙÀÚ±â°ø¸í
  • nuclear magnetic resonance spectroscopy
    ÇÙÀÚ±â°ø¸íºÐ±¤¹ý
  • nuclear paramagnetic resonance
    ÇÙ»óÀÚ¼º°ø¸í
  • nuclear polyhedrosis virus
    ÇÙÆú¸®Çìµå·ÐÇü¼º¹ÙÀÌ·¯½º
  • nuclear-cytoplasmic ratio
    ÇÙ¼¼Æ÷Áúºñ
  • progressive nuclear ophthalmoplegia
    ÁøÇà½Å°æÇÙ´«±ÙÀ°¸¶ºñ
  • respiratory acidosis
    È£Èí»êÁõ
  • respiratory alkalosis
    È£Èí¾ËÄ«¸®Áõ
  • respiratory apparatus
    È£Èí±â°ü
  • respiratory arrest
    È£ÈíÁ¤Áö
  • respiratory arrhythmia
    È£ÈíºÎÁ¤¸Æ
  • respiratory bag
    È£ÈíÁÖ¸Ó´Ï
  • respiratory bronchiole
    È£Èí¼¼±â°üÁö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • idiopathic respiratory distress of newborn infant =IRDNI
    ½Å»ý¾ÆÆ¯¹ß¼º È£Èí°ï¶õÁõ.
  • idiopathic respiratory distress syndrome
    Ư¹ß¼º È£Èí°ï¶õÁõÈıº.
  • pontine respiratory center
    ³ú±³È£ÈíÁßÃß(ÒàÎéû¼ýåñéõÒ).
  • rds=£¾respiratory distress syndrome
    È£Èí°ï¶õÁõÈıº(û¼ýåÍÝÑññøý¦ÏØ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nuclear body
    ÇÙü.
  • nuclear body
    µ¡ÇÙ¼Òü
  • nuclear bombardment
    ÇÙÃæµ¹
  • nuclear cardiology
    ½ÉÀåÇÙÀÇÇÐ.
  • nuclear cataract
    Çٹ鳻Àå(ú·ÛÜÒ®î¡).
  • nuclear chain
    Çٻ罽, ÇÙ¼â(ú·áð).
  • nuclear chain fiber
    Çٻ罽±ÙÀ°¼¼Æ÷
  • nuclear charge
    ÇÙÇÏÀü.
  • nuclear chromatin
    ÇÙ¿°»öÁú(ú·æøßäòõ).
  • nuclear division
    (¼¼Æ÷)Çٺп­(á¬øàú·ÝÂæñ).
  • nuclear dust
    ÇÙÁø
  • nuclear electron
    ÇÙ³»ÀüÀÚ(ú·Ò®ï³í­).
  • nuclear energy
    ÇÙ(ú·)¿¡³ÊÁö.
  • nuclear envelope
    ÇÙ¸·(ú·Ø¯).
  • nuclear fast red
    ÇÙ³»¼º Àû»ö¼Ò(ú·Ò±àõîåßä áÈ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • respiratory enzyme
    È£Èí È¿¼Ò(ý£áÈ)
  • respiratory enzyme complex
    È£Èí È¿¼Ò º¹ÇÕü(ÜÜùêô÷)
  • respiratory inhibitor
    È£Èí ÀúÇØÁ¦(îÁúªð¥)
  • respiratory pigment
    È£Èí »ö¼Ò(ßäáÈ)
  • respiratory poison
    È£Èí µ¶¼Ò(Ô¸áÈ)
  • respiratory protein
    È£Èí ´Ü¹éÁú(Ó±ÛÜòõ)
  • respiratory quotient
    È£Èí·ü(û¼ýå×Ë)
  • respiratory reduction
    È£Èí¼º ȯ¿ø(û¼ýåàõü½êª)
  • respiratory repression
    È£Èí ¾ïÁ¦(åäð¤)
  • Warburg's respiratory enzyme
    ¹Ù¸£ºÎ¸£Å© È£ÈíÈ¿¼Ò(û¼ýåý£áÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • respiratory ordered phase encoding
    È£Èí¼øÀ§»óºÎȣȭ
  • respiratory organ
    È£Èí±â
  • respiratory paralysis
    È£Èí¸¶ºñ
  • respiratory tract
    ±âµµ, È£Èí±âµµ
  • respiratory volume
    È£Èí¿ëÀû
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PF1-4 platelet factors 1 to 4
PQRST provocative and palliative factors, quality of pain, radiation of pain, severity of pain, timing of ...
PULSES physical condition, upper limb function, lower limb function, sensory component, excretory function,...
ARDS acute respiratory distress syndrome; adult respiratory distress syndrome
CRD carbohydrate-recognition domain; chronic renal disease; chronic respiratory disease; child restraint...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
GEF Guanine nucleotide Exchange Factors
HGF Hemopoietic growth factors
HBGF Heparin binding growth factors
IGFBPs Insulin-like growth factors and their binding proteins
IGF-II Insulin-like growth factors I and II
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • non-respiratory acidosis
    ºñÈ£Èí¼º »êÁõ
  • non-respiratory depressant drug
    ºñ-È£Èí ¾ïÁ¦Á¦
  • nonprotein respiratory quotient
    ºñ´Ü¹é È£Èí»ó
  • respiratory acidosis
    È£Èí¼º »êÁõ
    1. ÀÌ»êȭź¼Ò ºÐ¾ÐÀÇ Áõ°¡·Î »êµµ¿Í ¼ö¼Ò ÀÌ¿ÂÀÇ ³óµµ°¡ Áõ°¡Çϰí Áßź»ê¿°ÀÌ Áõ°¡ÇÑ´Ù. 2. °¨¼ÒµÈ ÆóÆ÷ ȯ±â¿Í µÚÀÌÀº °íź»êÇ÷ÁõÀ¸·ÎºÎÅÍ ³ª¿Â´Ù. È£Èí±â Áúȯ»Ó¸¸ ¾Æ´Ï¶ó ºñÈ£Èí±â Áúȯµµ Àúȯ±â¸¦ À¯¹ßÇÒ ¼ö ÀÖ´Ù. ÀÓ»ó°¡µéÀº ÈçÈ÷ ÃÖ¸éÁ¦·Î ÀÎÇÑ ÁßÃß ½Å°æ ¾ïÁ¦ ¶§¹®¿¡ »ý±â´Â È£Èí¼º »êÁõ°ú °°ÀÌ °¡¿ªÀûÀÎ ¿øÀο¡ ´ëÇØ ¹Ýµå½Ã »ó±âÇϰí ÀÖ¾î¾ß ÇÑ´Ù. ±Þ¼º È£Èí ºÎÀüÀº ½ÉÇÑ »êÁõ°ú Ç÷û Áßź»ê ÀÌ¿ÂÀÇ ¹Ì¹ÌÇÑ Áõ°¡¿Í ¿¬°üµÇ¾î ÀÖ´Ù. 6-12½Ã°£ µÚ¿¡ ÀÌ»êȭź¼Ò ºÐ¾ÐÀÇ ÀÏÂ÷ÀûÀÎ Áõ°¡°¡ ½ÅÀåÀÇ º¸»ó ¹ÝÀÀÀ» À¯¹ßÇÏ¿© ´õ ¸¹Àº ź»ê¿°À» ¸¸µé¾î ³»°í À̴ ȣÈí¼º »êÁõÀ» °³¼±½ÃŲ´Ù. º¸Åë ÀÌ ÀÛ¿ëÀ» ¿ÏÀüÈ÷ ÇÏ´Â µ¥ ¼ö ÀÏ °É¸°´Ù.
  • respiratory arrest
    È£Èí Á¤Áö
    µ¿ÀǾî=res
  • respiratory bag
    È£Èí ³¶
  • respiratory bronchiolitis
    È£Èí ¼¼±â°üÁö¿°
    ÀþÀº Èí¿¬°¡¿¡¼­ º¼ ¼ö ÀÖ´Â ¼Ò±âµµ ÁúȯÀÌ´Ù. ÀÓ»óÀûÀ¸·Î³ª ¹æ»ç¼± »çÁø»ó Ư¹ß¼º °£Áú¼º Æó ¼¶À¯È­Áõ°ú À¯»çÇÏ´Ù. ±âħ, È£Èí °ï¶õ, ûÁø»ó ¼öÆ÷À½ µîÀÌ Æ¯Â¡ÀÌ´Ù. Ư¹ß¼º °£Áú¼º Æó ¼¶À¯È­Áõ¿¡¼­ º¸ÀÌ´Â ÆóÀ¯¼øµµÀÇ °¨¼Ò´Â ÀÌ Áúȯ¿¡¼­´Â º¼ ¼ö ¾øÀ¸¸ç, °£È¤ °³Èä Æó »ý°Ë¿¡¼­ ¹ß°ßµÇ´Âµ¥ Á¶Á÷ °Ë»ç»ó ¸»´Ü ¼¼±â°üÁö¿Í È£Èí ¼¼±â°üÁö¿¡ Ư¡ÀûÀÎ ÀÌÇü¼º°ú »ö¼Ò Ä§Âø ¼¼Æ÷, ´ë½Ä ¼¼Æ÷¿¡ ÀÇÇÑ ÆóÆ÷, ÆóÆ÷°ü, ¸»´Ü ¹× È£Èí ¼¼±â°üÁöÀÇ ±âµµ ÃæÀüÀ» º¼ ¼ö ÀÖ´Ù.
  • respiratory center
    È£Èí ÁßÃß
  • respiratory dead space
    È£Èí¼º ¹«È¿ °ø°£
  • respiratory depression
    È£Èí ÀúÇÏ
  • respiratory distress syndrome
    È£Èí °ï¶õ ÁõÈıº
  • respiratory disturbance
    È£Èí Àå¾Ö
  • respiratory excitant
    È£Èí ÈïºÐ ¾à
  • respiratory function
    È£Èí ±â´É
  • respiratory gating
    È£Èí µ¿±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
haemolysin factors Plasmids controlling the synthesis of haemolysin by bacteria.
(12 Dec 1998)
precipitating factors Factors associated with the definitive onset of a disease, illness, accident, behavioural response, or course of action. Usually one factor is more important or more obviously recognizable than others, if several are involved, and one may often be regarded as "necessary". Examples include exposure to specific disease; amount or level of an infectious organism, drug, or noxious agent, etc.
(12 Dec 1998)
predisposing factors Attitudinal, personality, and related factors that motivate and guide an individual to take certain health actions.
(05 Mar 2000)
sex factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from sex characteristics, anatomical or physiological manifestations of sex, and from sex distribution, the number of males and females in given circumstances.
(12 Dec 1998)
socioeconomic factors Social and economic factors that characterise the individual or group within the social structure.
(12 Dec 1998)
steam conversion factors (approximations) 1 pound of steam = 1,000 Btu = .3 kW. 10,000 lbs/hr steam = 300 boiler horsepower.
(05 Dec 1998)
stem cell growth factors <growth factor> Compounds, usually proteins, that make stem cells grow faster.
(26 Mar 1998)
nerve growth factors Factors which enhance the growth potentialities of sensory and sympathetic nerve cells.
(12 Dec 1998)
debranching factors Enzyme's that bring about destruction of branches in glycogen; formerly considered to be one enzyme, now known to be a mixture of transferases (4-alpha-d-glucanotransferase) and hydrolases (amylo-1,6-glucosidase).
Synonym: debranching factors.
(05 Mar 2000)
suppressor factors, immunologic Proteins, protein complexes, or glycoproteins secreted by suppressor T-cells that inhibit either subsequent T-cells, B-cells, or other immunologic phenomena. Some of these factors have both histocompatibility (I-j) and antigen-specific domains which may be linked by disulfide bridges. They can be elicited by haptens or other antigens and may be mass-produced by hybridomas or monoclones in the laboratory.
(12 Dec 1998)
direct lytic factors most abundant proteins in cobra (naja of the elapids) venom; basic polypeptides of 57 to 62 amino acids with four disulfide bonds and a molecular weight of less than 7000; causes skeletal and cardiac muscle contracture, interferes with neuromuscular and ganglionic transmission, depolarises nerve, muscle and blood cell membranes, thus causing haemolysis.
Synonym: cobramine a; cobramine b; cobra cytotoxin; gamma toxin; membrane-active polypeptide.
(12 Dec 1998)
immunologic and biological factors A collective grouping for biologically active substances that play a role in the functioning of the immune system and those that show biological or physiological activity.
(12 Dec 1998)
immunologic factors Biologically active substances whose activities affect or play a role in the functioning of the immune system.
(12 Dec 1998)
initiation factors The set of catalytic proteins required, in addition to mRNA and ribosomes, for protein synthesis to begin. In bacteria three distinct proteins have been identified: if 1 (8 kD), IF 2 (75 kD) and IF 3 (30 kD). at least 6-8 proteins have been identified in eukaryotes. IFs 1 and 2 enhance the binding of initiator tRNA to the initiation complex.
(18 Nov 1997)
insulin-like growth factors Peptides whose formation is stimulated by growth hormone. These peptides bring about peripheral tissue effects of that hormone and have high (about 70%) homology to human insulin.
Synonym: somatomedins.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nuclear reaction
    ÇÙ¹ÝÀÀ
  • nuclear reactor
    ¿øÀÚ·Î
  • nuclear resonance
    ÇÙ°ø¸í
  • nuclear shelter
    ÇÙ´ëÇǼÒ
  • nuclear test
    ÇÙ½ÇÇè
  • nuclear test ban treaty
    ÇÙ½ÇÇè ±ÝÁö Á¶¾à
  • nuclear umbrella
    ÇÙ¿ì»ê
  • nuclear warhead
    ÇÙźµÎ
  • nuclear winter
    ÇÙÀÇ °Ü¿ï(ÇÙÀüÀïÀ¸·Î ÀÎÇÑ ÀüÁö±¸ÀûÀÎ ÇÑ·©Çö»ó
  • tactical nuclear weapon
    Àü¼ú ÇÙ¹«±â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á